Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
This competitive program supports independent education initiatives aimed at enhancing healthcare professionals' ability to manage cancer cachexia.
Característiques principals
Clinical Area: Cancer cachexia

Projects should focus on:
  • Recognizing the signs and symptoms of cachexia
  • Using diagnostic tools to assess, measure, and accurately document cachexia in patient records
  • Applying current strategies to improve appetite, lean body mass, or physical function in patients with cachexia
  • Understanding the role of GDF-15 and its potential as a therapeutic target in cachexia treatment
  • Identifying and considering patients for cachexia clinical trials, staying informed about emerging therapeutic options
  • Lloc de presentació
    HMRIB and PSMAR staff who need more information should contact:
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Júlia Vidal: [email protected] Ext.: 1736
    Convocatòria (URL)
    https://cdn.pfizer.com/pfizercom/2026-03/2026-ONC-GlobalCancerCachexia-IME.pdf
    Requisits
  • Organizations must be based in the United States, United Kingdom, France, Spain, Germany, Italy, or Japan, although proposals with global reach are also encouraged.
  • Eligible applicants may include medical, nursing, allied health, and pharmacy schools; hospitals and healthcare institutions; professional organizations or medical societies; medical education companies; and other entities involved in healthcare professional education or improvement.
  • Only organizations can receive grants; individuals are not eligible.
  • For collaborative projects, whether within a single institution or across multiple organizations, all partners must have relevant roles, and the requesting organization must play a key role.
  • Clinical research projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.
  • Dotació
    Up to $300,000
    Durada
    18 months

    Arxius

    Arxiu
    2026-ONC-GlobalCancerCachexia-IME.pdf